{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T20:50:51Z","timestamp":1787259051045,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770945"],"award-info":[{"award-number":["81770945"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670878"],"award-info":[{"award-number":["81670878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970809"],"award-info":[{"award-number":["81970809"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.biopha.2020.110248","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T17:38:21Z","timestamp":1590255501000},"page":"110248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Suppression of pathological ocular neovascularization by a small molecule, SU1498"],"prefix":"10.1016","volume":"128","author":[{"given":"Tao","family":"Shu-Ya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Qiu-Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jing-Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Biao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110248_bib0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ophtha.2011.01.041","article-title":"Horizons in therapy for corneal angiogenesis","volume":"118","author":"Maddula","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.biopha.2020.110248_bib0010","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/164_2016_78","article-title":"Anti-angiogenic therapy for retinal disease","volume":"242","author":"Paulus","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.biopha.2020.110248_bib0015","first-page":"3948","article-title":"Protective effects of matrix metalloproteinase-12 following corneal injury","volume":"126","author":"Chan","year":"2013","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.biopha.2020.110248_bib0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease","volume":"27","author":"Penn","year":"2008","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2020.110248_bib0025","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1755-3768.2011.02312.x","article-title":"The association between corneal neovascularization and visual acuity: a systematic review","volume":"91","author":"Bachmann","year":"2013","journal-title":"Acta Ophthalmol. (Copenh)"},{"key":"10.1016\/j.biopha.2020.110248_bib0030","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.exer.2003.09.005","article-title":"Anti-angiogenic role of angiostatin during corneal wound healing","volume":"78","author":"Gabison","year":"2004","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.biopha.2020.110248_bib0035","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","article-title":"Basic and therapeutic aspects of angiogenesis","volume":"146","author":"Potente","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.biopha.2020.110248_bib0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.preteyeres.2010.01.002","article-title":"Novel aspects of corneal angiogenic and lymphangiogenic privilege","volume":"29","author":"Ellenberg","year":"2010","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2020.110248_bib0045","doi-asserted-by":"crossref","first-page":"15","DOI":"10.22336\/rjo.2019.4","article-title":"Corneal neovascularization: updates on pathophysiology, investigations & management","volume":"63","author":"Sharif","year":"2019","journal-title":"Rom. J. Ophthalmol."},{"key":"10.1016\/j.biopha.2020.110248_bib0050","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.biomaterials.2017.02.016","article-title":"Subconjunctival injectable dendrimer-dexamethasone gel for the treatment of corneal inflammation","volume":"125","author":"Soiberman","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.biopha.2020.110248_bib0055","article-title":"IKK2 inhibition attenuates laser-induced choroidal neovascularization","volume":"9","author":"Lu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2020.110248_bib0060","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1161\/CIRCULATIONAHA.117.029004","article-title":"Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in diabetes mellitus","volume":"136","author":"Shan","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2020.110248_bib0065","first-page":"18","article-title":"Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization","volume":"39","author":"Amano","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2020.110248_bib0070","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1172\/JCI20465","article-title":"VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment","volume":"113","author":"Cursiefen","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.biopha.2020.110248_bib0075","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1161\/CIRCULATIONAHA.118.036099","article-title":"Endothelial cells regulate physiological cardiomyocyte growth via VEGFR2 -mediated paracrine signaling","volume":"139","author":"Kivel\u00e4","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2020.110248_bib0080","first-page":"264","article-title":"Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)","volume":"104","author":"Azar","year":"2006","journal-title":"Trans. Am. Ophthalmol. Soc."},{"key":"10.1016\/j.biopha.2020.110248_bib0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.preteyeres.2003.08.001","article-title":"Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition","volume":"22","author":"Das","year":"2003","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.biopha.2020.110248_bib0090","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/157339909787314149","article-title":"Diabetic retinopathy and angiogenesis","volume":"5","author":"Crawford","year":"2009","journal-title":"Curr. Diabetes Rev."},{"key":"10.1016\/j.biopha.2020.110248_bib0095","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1590\/S0004-27302011000200002","article-title":"The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy","volume":"55","author":"Valiatti","year":"2011","journal-title":"Arq. Bras. Endocrinol. Metabol."},{"key":"10.1016\/j.biopha.2020.110248_bib0100","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/s41467-019-09605-z","article-title":"N-terminal syndecan-2 domain selectively enhances 6-O heparan sulfate chains sulfation and promotes VEGFA165-dependent neovascularization","volume":"10","author":"Corti","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.110248_bib0105","doi-asserted-by":"crossref","DOI":"10.1242\/dev.151019","article-title":"Vascular endothelial growth factor signaling in development and disease","volume":"145","author":"Karaman","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.biopha.2020.110248_bib0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/08820538.2011.588652","article-title":"Inflammatory corneal neovascularization: etiopathogenesis","volume":"26","author":"Clements","year":"2011","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.biopha.2020.110248_bib0115","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/00055735-200108000-00002","article-title":"Corneal neovascularization","volume":"12","author":"Chang","year":"2001","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.biopha.2020.110248_bib0120","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/cbdd.13018","article-title":"Recent drug therapies for corneal neovascularization","volume":"90","author":"Liu","year":"2017","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.biopha.2020.110248_bib0125","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrm.2016.87","article-title":"Mechanisms and regulation of endothelial VEGF receptor signalling","volume":"17","author":"Simons","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2020.110248_bib0130","doi-asserted-by":"crossref","first-page":"E1264","DOI":"10.3390\/ijms19041264","article-title":"Molecular pharmacology of VEGF-A isoforms: binding and signalling at VEGFR2","volume":"19","author":"Peach","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2020.110248_bib0135","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2020.110248_bib0140","doi-asserted-by":"crossref","first-page":"5875","DOI":"10.1158\/1078-0432.CCR-14-1071","article-title":"Ramucirumab: successfully targeting angiogenesis in gastric cancer","volume":"20","author":"Javle","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2020.110248_bib0145","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.carbpol.2019.04.058","article-title":"Preparation of manganese oxides coated porous carbon and its application for lead ion removal","volume":"219","author":"Tan","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2020.110248_bib0150","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1038\/s41467-018-06981-w","article-title":"Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery","volume":"9","author":"Than","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.110248_bib0155","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1167\/iovs.09-4956","article-title":"A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap","volume":"51","author":"Cao","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.biopha.2020.110248_bib0160","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2020.110248_bib0165","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1038\/s41467-018-05812-2","article-title":"SUMOylation of VEGFR2 regulates its intracellular trafficking and pathological angiogenesis","volume":"9","author":"Zhou","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2020.110248_bib0170","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4137\/OED.S32200","article-title":"Targeting MAPK signaling in age-related macular degeneration","volume":"8","author":"Kyosseva","year":"2016","journal-title":"Ophthalmol. Eye Dis."},{"key":"10.1016\/j.biopha.2020.110248_bib0175","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bbadis.2009.12.009","article-title":"Pathological roles of MAPK signaling pathways in human diseases","volume":"1802","author":"Kim","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2020.110248_bib0180","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00204-015-1472-2","article-title":"Compromised MAPK signaling in human diseases: an update","volume":"89","author":"Kim","year":"2015","journal-title":"Arch. Toxicol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220304406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T23:11:41Z","timestamp":1778541101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220304406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":36,"alternative-id":["S0753332220304406"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110248","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of pathological ocular neovascularization by a small molecule, SU1498","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110248","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110248"}}